SEZI — Senzime AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK660.30m
- SEK626.74m
- SEK104.02m
Brief: Senzime Signs Strategic License And Connectivity Agreement
Brief: Senzime Enters Into Agreement To Buy U.S. Company Respiratory Motion
Brief: Senzime Completes Directed Share Issue
Brief: Senzime Q1 Loss After Financial Items SEK 21.0 Mln
Brief: Senzime Gets CE-MDR Approval For Disposable Sensor For Small Children
Brief: Senzime Gets US Order With An Initial Value Exceeding SEK 1 Mln
Brief: Senzime Wins US Deal For 23 Tetragraph Systems
Brief: Senzime Applies For FDA Approval For New Single-Use Sensor For Children
Brief: Senzime Signs Deal For 50 Tetragraph Systems Worth About SEK 1.5 Mln Per Year
Brief: Senzime Q4 Loss After Financial Items Widens To SEK 24.4 Mln
Brief: Senzime Secures Sales In 16 Hospitals In Q4 of 2021
Brief: Senzime Apoints Slavoljub Grujicic As New CFO
Brief: Senzime Q3 Loss After Financial Items Widens To SEK 19.7 Million
Brief: Senzime Updates On Business, Markets And Key Figures
Brief: Senzime Q2 Pretax Loss Widens To SEK 22.6 Mln
Brief: Senzime Is Approved For Listing On Nasdaq Stockholm
Brief: Senzime Q1 Operating Loss Before Depreciation At SEK 14.9 Mln
Brief: Senzime Expands Commercial Capability In U.S
Brief: Senzime Q4 Loss After Financial Items Widens To SEK 15.6 Mln